Author

Renee Fedak

Observed name: Renee R. Fedak

Institution: Cartesian Therapeutics, Inc. (United States)

Observed institutions: Johns Hopkins University, Cartesian Therapeutics, Inc. (United States), University of Maryland, College Park

ORCID: 0000-0003-4284-9283

Observed ORCID: 0000-0003-4284-9283

OpenAlex ID: A5014107810

High Throughput Nanoliposome Formation Using 3D Printed Microfluidic Flow Focusing Chips

2019 · Zhu Chen, Jung Yeon Han, et al. · Advanced Materials Technologies · 68

High Molecular Weight DNA Extraction from Recalcitrant Plant Species for Third Generation Sequencing v1

2018 · Rachael Workman, Winston Timp, et al. · 51

BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial

2026 · Tuan Vu, Hacer Durmus, et al. · Nature Medicine · 38

High Molecular Weight DNA Extraction from Recalcitrant Plant Species for Third Generation Sequencing v1

2019 · Rachael Workman, Renee Fedak, et al. · 30

BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial

2026 · Renee R. Fedak, Rachel N. Ruggerie, et al. · Nature Medicine · 24

Post-hoc Analysis of Descartes-08, BCMA-directed mRNA CAR-T Therapy, in Biologic Non-responsive Versus Biologic Naive Generalized Myasthenia Gravis: Results from a Phase 2b Randomized Trial (P9-9.020)

2026 · Milos Miljkovic, Tuan Vu, et al. · Neurology

High-Throughput, High MW DNA Extraction and Size Selection for Long-Read Sequencing.

2019 · Kun Liu, J. F. Burke, et al. · PubMed Central

Works count: 7

Citation count: 211

H-index: 5

I10-index: 5